Véronique Pagé

1.2k total citations
18 papers, 599 citations indexed

About

Véronique Pagé is a scholar working on Psychiatry and Mental health, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Véronique Pagé has authored 18 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 4 papers in Epidemiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Véronique Pagé's work include Chronic Disease Management Strategies (4 papers), Diabetes Management and Education (4 papers) and Schizophrenia research and treatment (4 papers). Véronique Pagé is often cited by papers focused on Chronic Disease Management Strategies (4 papers), Diabetes Management and Education (4 papers) and Schizophrenia research and treatment (4 papers). Véronique Pagé collaborates with scholars based in Canada, United States and Germany. Véronique Pagé's co-authors include Norbert Schmitz, Ghislaine Badawi, Geneviève Gariépy, Kimberley J. Smith, Mélanie Béland, Rémi Rabasa‐Lhoret, Matthew Clyde, Natalie Grizenko, Ridha Joober and Ganesh A. Thakur and has published in prestigious journals such as Blood, Journal of Affective Disorders and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Véronique Pagé

18 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Véronique Pagé Canada 12 226 123 96 90 85 18 599
Ghislaine Badawi Canada 9 217 1.0× 131 1.1× 83 0.9× 51 0.6× 45 0.5× 12 548
Fleur E. P. van Dooren Netherlands 7 289 1.3× 193 1.6× 185 1.9× 67 0.7× 99 1.2× 8 673
Matthew Clyde Canada 9 250 1.1× 143 1.2× 96 1.0× 35 0.4× 82 1.0× 13 533
Eva Graham Canada 11 124 0.5× 89 0.7× 73 0.8× 41 0.5× 61 0.7× 20 491
Catherine P. Sanford United States 8 116 0.5× 81 0.7× 121 1.3× 145 1.6× 41 0.5× 8 475
Calum D. Moulton United Kingdom 14 386 1.7× 271 2.2× 158 1.6× 149 1.7× 177 2.1× 36 1.1k
Anne Engum Norway 5 468 2.1× 205 1.7× 118 1.2× 92 1.0× 49 0.6× 6 675
Anna-Karin Eriksson Sweden 10 125 0.6× 71 0.6× 61 0.6× 39 0.4× 48 0.6× 12 490
L A Palinkas United States 11 293 1.3× 108 0.9× 226 2.4× 139 1.5× 151 1.8× 14 941
Katherine Semenkovich United States 8 276 1.2× 91 0.7× 72 0.8× 38 0.4× 73 0.9× 16 501

Countries citing papers authored by Véronique Pagé

Since Specialization
Citations

This map shows the geographic impact of Véronique Pagé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Pagé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Pagé more than expected).

Fields of papers citing papers by Véronique Pagé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Pagé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Pagé. The network helps show where Véronique Pagé may publish in the future.

Co-authorship network of co-authors of Véronique Pagé

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Pagé. A scholar is included among the top collaborators of Véronique Pagé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Pagé. Véronique Pagé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lepage, Pierre, Véronique Pagé, Caroline Levasseur, et al.. (2023). Strategies to improve access to physical activity opportunities for people with physical disabilities. Translational Behavioral Medicine. 13(7). 486–500. 8 indexed citations
2.
Tanner, Caroline M., et al.. (2023). Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study. Journal of Patient-Reported Outcomes. 7(1). 21–21. 1 indexed citations
3.
Koch, Jordan, Véronique Pagé, Jean Ramsay, et al.. (2021). Physical activity for individuals living with a physical disability in Quebec: Issues and opportunities of access. Disability and health journal. 14(3). 101089–101089. 11 indexed citations
4.
Sweet, Shane N., Meredith Rocchi, Jean Ramsay, et al.. (2021). Longitudinal Examination of Leisure-Time Physical Activity (LTPA), Participation, and Social Inclusion Upon Joining a Community-based LTPA Program for Adults With Physical Disabilities. Archives of Physical Medicine and Rehabilitation. 102(9). 1746–1754. 12 indexed citations
5.
Cutler, Andrew J., et al.. (2021). Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study. Journal of the American Psychiatric Nurses Association. 29(5). 389–399. 7 indexed citations
6.
Caroff, Stanley N., Karen Yeomans, William R. Lenderking, et al.. (2020). RE-KINECT. Journal of Clinical Psychopharmacology. 40(3). 259–268. 25 indexed citations
7.
Proskorovsky, Irina, Yun Su, Kyle Fahrbach, et al.. (2019). Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia. Advances in Therapy. 36(8). 2147–2160. 14 indexed citations
8.
9.
Stelljes, Matthias, Yun Su, Kyle Fahrbach, et al.. (2017). Indirect Treatment Comparison (ITC) of Inotuzumab Ozogamicin (InO) and Blinatumomab (Blina) for Relapsed or Refractory (RR) Acute Lymphoblastic Leukemia (ALL). Blood. 130. 2558–2558. 1 indexed citations
10.
Badawi, Ghislaine, Geneviève Gariépy, Véronique Pagé, & Norbert Schmitz. (2012). Indicators of self‐rated health in the Canadian population with diabetes. Diabetic Medicine. 29(8). 1021–1028. 45 indexed citations
11.
Badawi, Ghislaine, Véronique Pagé, Kimberley J. Smith, et al.. (2012). Self-rated health: A predictor for the three year incidence of major depression in individuals with Type II diabetes. Journal of Affective Disorders. 145(1). 100–105. 37 indexed citations
12.
Smith, Kimberley J., Mélanie Béland, Matthew Clyde, et al.. (2012). Association of diabetes with anxiety: A systematic review and meta-analysis. Journal of Psychosomatic Research. 74(2). 89–99. 312 indexed citations
13.
Thakur, Ganesh A., et al.. (2012). Maternal Smoking During Pregnancy and ADHD: A Comprehensive Clinical and Neurocognitive Characterization. Nicotine & Tobacco Research. 15(1). 149–157. 43 indexed citations
14.
Choudhry, Zia, Sarojini M. Sengupta, Véronique Pagé, et al.. (2012). Catechol-O-Methyltransferase Gene and Executive Function in Children With ADHD. Journal of Attention Disorders. 18(3). 202–211. 6 indexed citations
15.
Smith, Kimberley J., Véronique Pagé, Geneviève Gariépy, et al.. (2011). Self-rated diabetes control in a Canadian population with type 2 diabetes: Associations with health behaviours and outcomes. Diabetes Research and Clinical Practice. 95(1). 162–168. 12 indexed citations
16.
Moore, Kenneth Todd, et al.. (2010). A Randomized Study of the Effects of Food on the Pharmacokinetics of Once-Daily Extended-Release Hydromorphone in Healthy Volunteers. The Journal of Clinical Pharmacology. 51(11). 1571–1579. 12 indexed citations
17.
Browne, Marilyn L., C. C. Vernon, Véronique Pagé, et al.. (2007). Fortification of selected foodstuffs with folic acid in the UK: consumer research carried out to inform policy recommendations. Journal of Public Health. 30(1). 23–29. 14 indexed citations
18.
Hamet, Pavel, Michael Kaiser, Yingxian Sun, et al.. (1996). HSP27 locus cosegregates with left ventricular mass independently of blood pressure.. PubMed. 28(6). 1112–7. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ghislaine Badawi Breakdown of academic impact, for papers by Fleur E. P. van Dooren Breakdown of academic impact, for papers by Matthew Clyde Breakdown of academic impact, for papers by Eva Graham Breakdown of academic impact, for papers by Catherine P. Sanford Breakdown of academic impact, for papers by Calum D. Moulton Breakdown of academic impact, for papers by Anne Engum Breakdown of academic impact, for papers by Anna-Karin Eriksson Breakdown of academic impact, for papers by L A Palinkas Breakdown of academic impact, for papers by Katherine Semenkovich
Rankless by CCL
2026